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The cerebellum assists coordination of somatomotor, respiratory, and autonomic 
actions. Purkinje cell alterations or loss appear in sudden infant death and sudden death 
in epilepsy victims, possibly contributing to the fatal event. We evaluated breathing pat-
terns in 12 wild-type (WT) and Lurcher mutant mice with 100% developmental cerebellar 
Purkinje cell loss under baseline (room air), and recovery from hypercapnia, a concern 
in sudden death events. Six mutant and six WT mice were exposed to 4-min blocks 
of increasing CO2 (2, 4, 6, and 8%), separated by 4-min recovery intervals in room air. 
Breath-by-breath patterns, including depth of breathing and end-expiratory pause (EEP) 
durations during recovery, were recorded. No baseline genotypic differences emerged. 
However, during recovery, EEP durations significantly lengthened in mutants, compared 
to WT mice, following the relatively low levels of CO2 exposure. Additionally, mutant 
mice exhibited signs of post-sigh disordered breathing during recovery following each 
exposure. Developmental cerebellar Purkinje cell loss significantly affects compensatory 
breathing patterns following mild CO2 exposure, possibly by inhibiting recovery from 
elevated CO2. These data implicate cerebellar Purkinje cells in the ability to recover from 
hypercarbia, suggesting that neuropathologic changes or loss of these cells contribute 
to inadequate ventilatory recovery to increased environmental CO2. Multiple disorders, 
including sudden infant death syndrome (SIDS) and sudden unexpected death in epilepsy 
(SUDEP), appear to involve both cardiorespiratory failure and loss or injury to cerebellar 
Purkinje cells; the findings support the concept that such neuropathology may precede 
and exert a prominent role in these fatal events.
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inTrODUcTiOn
Sudden unexpected death occurs in several syndromes, with mechanisms underlying the fatal event 
not yet understood. Sudden infant death syndrome (SIDS) is one such syndrome; the condition 
occurs in infants <1 year of age, often during sleep, and with victims succumbing suddenly with 
major causes excluded even after autopsy and a thorough investigation (1, 2). Sudden death in epilepsy 
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(SUDEP), appears in adults as well as older children, often occurs 
during sleep, but leaves few signs of mechanisms operating to 
induce a fatal event. A defect in breathing, or deficient responses 
to a ventilatory challenge is suspected in both SIDS and SUDEP. 
Although an inability to respond to severe, transient hypotension 
is a strong possibility (3, 4), the circumstances surrounding both 
SIDS and SUDEP conditions suggest an unknown brain abnor-
mality that results in an inability to appropriately compensate for, 
or recover from, exposure to an intrinsic or exogenous stressor 
(5). Here, we evaluate the role of the cerebellum in mediating the 
consequences of exposure to one exogenous stressor, increased 
levels of environmental carbon dioxide (CO2; hypercapnia).
The focus on high CO2 arises from the circumstances normally 
associated with SIDS or postictal cessation of breathing in epi-
lepsy. SIDS and SUDEP victims are often found deceased in bed, 
in the prone position, and sometimes in soft bedding, focusing 
attention on exposure to elevated CO2 concentrations associ-
ated with these conditions during sleep (6, 7). Thus, SIDS likely 
results from an inability to respond appropriately with respiratory 
and cardiovascular patterns to accommodate such a breathing 
stressor. Similarly, postictal respiratory failure in SUDEP would 
elevate CO2 levels, imposing a breathing challenge that brain 
structures may not be able to manage.
Structures within the cerebellum play a significant role in 
responding to extreme respiratory or blood pressure challenge 
(8–11). Developmental neuropathology of the cerebellum, as 
well as surgical or other insult to this structure, is accompanied 
by various forms of disordered breathing, including apnea, 
obstructive apnea, and hypoventilation (12–16). Such disordered 
breathing induces substantial increases in markers for CO2 
(17), which, if not compensated, could place the subject at risk. 
Cerebellar neuropathology appears in SIDS victims, with a higher 
incidence of delayed cerebellar cortex maturation (18), and 
increased Purkinje cell apoptosis than controls (19). Cerebellar 
injury is very common in patients with epilepsy, likely induced 
either by excitotoxic injury or as a consequence of long-term 
antiepileptic medication. Additionally, in SIDS, transcriptional 
nucleolar activity is significantly reduced in cerebellar Purkinje 
cells relative to controls, suggesting hypofunction of the Purkinje 
cells in these victims. The nature of mechanisms underlying these 
pathologies or whether they underlie failure is unknown (20).
Cerebellar Purkinje cells provide the sole output of the cer-
ebellar cortex, and innervate the deep cerebellar nuclei which, in 
turn, send efferents to multiple areas of the brainstem involved in 
respiratory and autonomic functions (21, 22). One pair of nuclei, 
the fastigial nuclei (FN), is responsive to chemical respiratory 
challenges, with cell body lesions of these nuclei significantly 
attenuating compensatory respiratory responses to increased 
levels of environmental CO2. However, such lesions have little 
effect on relaxed, rhythmic breathing (10, 23). Additionally, 
Lurcher mutant mice (Lc/+) with global, developmental cerebel-
lar Purkinje cell loss show reduced respiratory responses follow-
ing exposure to increased environmental CO2 (24), an outcome 
interpreted as a reduction in sensitivity to increased blood CO2 
levels (25–27).
Exposure to increased CO2 in the environment is commonly 
encountered in everyday life, resulting in robust physiological 
responses, even with small increases in CO2 (26). The phenotypic 
response to rising CO2 levels is to increase minute ventilation 
by adjusting the depth of breathing [tidal volume (TV)], the 
frequency of breathing, or both (25–27). Recovery from ventila-
tory challenges results in a gradual return to baseline minute 
ventilation as blood levels of CO2 decrease and blood levels of 
oxygen (O2) increase (26). Disordered breathing patterns dur-
ing recovery from environmental stressors indicate respiratory 
distress and can include periods of abnormally large TVs (sighs) 
coupled with apneic-like periods of extended pauses between 
breaths [end-expiratory pause (EEP)]. Large TVs and extended 
EEPs limit the ability to reduce increased blood levels of CO2 by 
reducing the rate of gas exchange in the lungs (28). As disordered 
breathing patterns would reduce the ability to appropriately 
respond to, or recover from, exposure to exogenous stressors 
including hypercapnia or hypoxia, it has been suggested that 
such respiratory dysregulation could increase vulnerability to 
SIDS (29–31).
To determine if loss of cerebellar Purkinje cells results in 
distressed breathing following exposure to increased environ-
mental CO2, we used whole body plethysmography (WBP) to 
investigate the hypothesis that Lurcher mutants heterozygous 
for the Lurcher spontaneous mutation (Grid2Lc), would exhibit 
disordered breathing patterns during recovery from hypercapnia, 
in comparison to wild-type (WT) controls. Lurcher mice were 
selected because we had previously observed that deficits in 
breath frequency appeared during recovery, following exposure 
to low levels of CO2 (24). In the current study, we specifically 
targeted two components of breath frequency, including TV and 
EEP periods. These dependent variables were selected because of 
their importance in modulating increased blood levels of CO2 by 
affecting the rate of gas exchange in the lungs.
MaTerials anD MeThODs
animals
Mice were bred and housed in the Animal Care Facility of 
the Department of Psychology at the University of Memphis. 
They were maintained in a temperature-controlled environ-
ment (21 ± 1°C) on a 12:12 light–dark cycle (lights on at 0700 
hours) and given free access to food and water. Original Lurcher 
(#001046; Mouse Genome Identifier #: 1857337) breeders were 
purchased from The Jackson Laboratory (Bar Harbor, ME, USA). 
All experiments were conducted with strict adherence to the 
National Institutes of Health Guidelines for the Care and Use of 
Laboratory Animals. The protocol was approved by the University 
of Memphis Institutional Animal Care and Use Committee.
The breeding of Lurcher mice entailed filial pairing of a 
non-ataxic female WT (B6CBACa Aw-J/A-Grid2+) with a mutant 
ataxic male heterozygous for the Lurcher spontaneous mutation 
(B6CBACa Aw-J/A-Grid2Lc). This breeding strategy produced lit-
ters that are composed of both heterozygous Lc/+ and WT mice. 
The Lc/+ mouse is phenotypically distinguishable from WT 
littermates as early as postnatal day 12 (PND 12) with cerebellar 
signs, including an ataxic gait, which permits non-invasive dif-
ferentiation of Lc/+ mice from their non-ataxic WT littermates 
(32, 33).
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Animals were weaned at PND 25 ± 4 days, and sibling housed 
in groups of three to five in ventilated polystyrene cages. In 
order to avoid litter effects, six Lc/+ and six WT littermates were 
selected randomly, each pair from different litters and mating 
cages. All mice were PND 60 at testing onset with a mean weight 
of 20.05 g (SD = 1.79 g). The subjects consisted of 12 male mice. 
Male mice were chosen because the incidence of sudden death 
and cerebellar neuropathology is much larger in males than in 
females (1, 34).
Whole Body Plethysmography
Experimental data were collected during light hours using a 
WBP system (Emka Technologies, Falls Church, VA, USA), as 
previously described (24). Briefly, a transducer was mounted to 
the WBP device, which converted pressure differentials in the 
chamber caused by respiration into electrical signals that were 
then transmitted to, and interpreted by, the software. Data were 
collected for each individual breath with sampling rates set at 
least twice the typical eupneic breathing levels observed in mice: 
typical TV <30 mL, typical expired volume <30 mL, and typical 
breath frequency <500/bpm (35, 36), to account for changes in 
breathing due to the response to, and recovery from hypercap-
nia. Pressure differentials that met all of these requirements, as 
interpreted by the software, were counted as individual breaths 
and added to the data output. Differentials that did not meet all 
of these parameters were flagged as movement artifacts and not 
included in the data file for analysis.
Procedure
Mice were weighed prior to placement in the WBP chamber. 
The experimental room temperature (22 ±  3°C) and humidity 
(20 ± 5%) were monitored daily to ensure stability throughout the 
study. An in-house program coupled to EMKA software was used 
to assess the subjects’ respiratory responses at baseline (normal 
room air: 21% O2, 0% CO2, and 79% N2), under conditions of 
increased CO2 (2, 4, 6, and 8%), and during recovery from each 
CO2 challenge in normal room air. Each test day began with a 
10-min habituation period, followed by a 4-min exposure to 
baseline (room air) period. Under all conditions, air in the WBP 
chamber was removed continuously (0.8–1.0  L/m), to prevent 
accumulation of excessive CO2 due to exhalation.
Baseline
After the 10-min habituation period, the dependent variables 
TV and EEP were continuously recorded, while the mice were 
exposed to room air for a total of 4 min (21% O2, 0% CO2, and 
79% N).
Hypercapnia and Recovery
The entire hypercapnia program was 52  min in duration and 
consisted of an initial baseline (4  min) measured as described 
above, followed by four sequential challenges where CO2 
content was progressively increased from 2, 4, 6, and 8% (21% 
O2, N2 on balance). Each of the four CO2 challenges consisted 
of a 2-min chamber fill period (the approximate time required 
for the WBP to fully achieve the desired gas percentages), fol-
lowed by a 4-min exposure. To assess the recovery responses to 
multiple hypercapnic challenges, the program returned to room 
air  following each challenge (again, including a 2-min chamber 
refill period and a 4-min recovery period). At termination of the 
final CO2 exposure (8%), and return to room air, the mouse was 
removed from the chamber.
Variables and Data analysis
To maintain sample equality among all animals on the measure 
of breath frequency, the dependent variables, TVs and EEPs, 
were recorded for the first 510 breaths from each animal during 
baseline and during recovery from each of the CO2 challenge 
conditions. Because TV and EEP are each components of breath 
frequency, the breath samples from each animal were made equal 
at 510 breaths based on the animal with the lowest breaths per 
minute. Analyses were only conducted on individual breaths to 
specifically determine if genotypic differences in TVs and EEP 
durations contributed to previously observed deficits in overall 
breath frequency during recovery from increased levels of CO2.
Animal Weights
An independent samples t-test was performed with genotype 
(Lc/+ and WT) as the independent variable and weights as the 
dependent variable to determine whether there was a need to 
include weight as a covariate, since lung function is tightly cor-
related with body size (37).
Baseline
Baseline data were analyzed using repeated measures analysis 
of variance (RMANOVA), with genotype (Lc/+ and WT) as 
the between-subjects factor and with the first 510 breaths as 
the within-subjects factors. Thus, the omnibus analysis was a 2 
(Genotype) × 510 (Breaths) mixed design.
Hypercapnia Recovery
The recovery conditions were analyzed using an omnibus 
RMANOVA with genotype (Lc/+ and WT) again serving as 
the between-subjects factor. Within-subjects factors included 
four levels of recovery from CO2 exposure (2, 4, 6, and 8% 
CO2), and from each recovery period, the first 510 breaths to 
accurately track TVs and moment-to-moment changes in EEP. 
Therefore, the omnibus analysis became a 2 (Genotype) ×  4 
(Recovery from CO2 exposure) × 510 (Breaths) mixed design. 
Depending on the results of the omnibus RMANOVAs, addi-
tional simple-effects tests were used to analyze interaction 
effects.
resUlTs
animals
An independent samples t-test revealed no significant difference 
between the body weights of the two genotypes, t(10) = −0.497, 
p = 0.630.
Baseline
The omnibus RMANOVA revealed the depth of breathing 
(TV) in the two groups was equivalent during normal room air 
FigUre 1 | Baseline tidal volume (a) and end-expiratory pause (B) 
data for 510 breaths at normal room air in Lurcher mutant (Lc/+) and 
wild-type (WT) control mice. Breaths have been averaged into groups of 
10 for clarity of presentation. Values represent mean ± SEM.
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[Lc/+ M = 0.158 mL, WT M = 0.170 ms, SEM 0.013 mL; Group, 
F(1, 10) =  0.879, p =  0.371]. Figure  1A shows the mean TVs 
of the two groups for the first 510 breaths. Note that breaths 
have been averaged into groups of 10 for clarity of presentation 
[Breath, F(509, 5090) = 0.970, p = 0.670; Group × Breaths, F(509, 
5090) = 0.900, p = 0.940].
A second omnibus RMANOVA further revealed the two geno-
types had equivalent EEP durations during exposure to room air 
[Lc/+ M = 11.819 ms, WT M = 11.922 ms, SEM 1.233 ms; Group, 
F(1, 10) =  0.007, p =  0.935]. As shown in Figure  1B, the two 
groups maintained equivalent EEP intervals throughout the 
continuum of 510 breaths and across individual breaths [Breath, 
F(509, 5090)  =  0.891, p  =  0.957; Group  ×  Breaths, F(509, 
5090) = 1.011, p = 0.427].
hypercapnia recovery
Figure  2A shows changes in average TV during recovery fol-
lowing each exposure to CO2. Changes in TV were comparable 
in the two genotypes. Mice in both groups showed a typical 
increase in TV following exposure to increasing percentages of 
CO2, indicating increased work to reduce the body burden of 
CO2 [2, 4, 6, and 8% CO2; Recovery, F(3, 30) = 3.765, p = 0.021]. 
Additionally, when considered across the 510 breaths within each 
recovery condition, both genotypes showed a gradual decline in 
TV, likely corresponding to gradual reductions in body levels of 
CO2 with the return to room air [data not shown; Breaths, F(509, 
5090) = 1.420, p < 0.001].
As shown in Figure 2B, when comparing recovery condi-
tions, EEPs between the two genotypes differed significantly 
[Recovery  ×  Group, F(3, 30)  =  4.044, p  =  0.016]. Simple-
effects tests revealed that Lc/+ mice had significantly longer 
average EEP periods than WT mice during recovery from 2 
and 4% CO2 [2% Group, F(1, 10) = 6.295, p = 0.031; 4% Group, 
F(1, 10) = 6.457, p = 0.029]. Although genotypic differences 
only approached significance following exposure to 6% CO2 
[Group, F(1, 10) = 3.128, p = 0.107], there was an interval of 
approximately 100 breaths when Lc/+ mice had significantly 
longer EEPs than WT controls during recovery from 6% CO2 
[data not shown; Group  ×  Breaths, F(509, 5090)  =  1.114, 
p = 0.046].
Figure  3, graphically illustrates the pattern of individual 
breaths from a representative mutant and WT mouse at the 
midpoint of each 4-min recovery period following successive 
CO2 exposures. Each panel of this figure includes the entire data 
form, over 10-s containing approximately 40 breaths. Visually, 
the two genotypes differed greatly in their breathing patterns. 
During the recovery periods following CO2 exposure, the Lc/+ 
mice exhibited a distinctly abnormal respiratory pattern, visually 
consistent with previous reports of post-sigh apnea in mice (38). 
Thus, the Lc/+ mouse had abnormally deep breaths (>100% of 
the average TV over the previous 10-s), which were followed by 
multiple breaths consisting of atypically long EEPs (>100% of the 
average over the previous 10-s). The WT mice, however, did not 
exhibit this pattern of disordered breathing, maintaining a more 
uniform pattern, including TVs and EEPs that did not differ in 
volume or length.
DiscUssiOn
Lc/+ mice and their WT littermates showed similar patterns of 
respiration when breathing room air at baseline. This finding 
further substantiates earlier results, indicating that cerebellar 
Purkinje cell loss has little effect on components of eupneic 
breathing (11, 12, 24).
The main outcomes of this study are that developmental loss of 
cerebellar Purkinje cells significantly reduced the ability of mice to 
compensate for the increased body burden of CO2 as indicated by 
FigUre 2 | recovery tidal volume (a) and end-expiratory pause (B) 
data, averaged across 510 breaths at room air (21% O2, 79% n2, and 
0% cO2), following each cO2 exposure period in Lurcher mutant 
(Lc/+) and wildtype (WT) mice. Values represent mean ± SEM. Asterisks 
indicate significant differences found between genotypes.
5
Calton et al. Cerebellar Neuropathology and Disordered Breathing
Frontiers in Neurology | www.frontiersin.org May 2016 | Volume 7 | Article 78
extended EEP periods following exposure to relatively low levels 
of hypercapnia. This is important because reduced compensatory 
responses to the increased body burden of CO2 would result in 
prolonged hypoxemia, which itself could facilitate the cardiores-
piratory failure that likely precedes sudden death events (28, 30). 
A similar pattern of disordered breathing has been documented 
in a report of sudden onset gasping and apnea in nine infants who 
subsequently died from SIDS (39). Collectively this preclinical and 
clinical evidence indicates the importance of evaluating breathing 
patterns and their potential contribution to impending fatal 
events. That Lc/+ mutants breathing approximated WT levels at 
8% further suggests that the threshold for detection for rising levels 
of CO2 in the mutants is much higher than that observed in control 
mice. This putative deficit in sensitivity to low levels of CO2 likely 
results in a reduced ability to compensate for rising blood levels 
of CO2 and the reduced ability to recover homeostatic ventilatory 
patterns. Since the cardiovascular system is closely integrated with 
breathing, disordered cardiovascular patterns, including cerebral 
blood flow, blood pressure, and heart rate, likely simultaneously 
occur (25–27). This possibility deserves further investigation.
Mechanisms potentially responsible for the patterns of disor-
dered breathing observed in Lc/+ mice are unlikely to include 
peripheral muscular deficits, as Lc/+ mice show more fatigue-
resistant diaphragm musculature than WT mice (40). Relatedly, 
a previous examination of the diaphragm in near-miss sudden 
death infants also revealed more fatigue-resistant diaphragm 
muscles compared to controls (41).
A more likely mechanism for the deficits in the recovery pat-
terns of Lc/+ mice involves the absence of Purkinje cell input to 
the FN. The FN are predominately innervated by Purkinje cells 
of the cerebellum, especially those originating from the vermis, 
and serve significant roles in cardiorespiratory compensatory 
responses to multiple challenges, including hypercapnia and 
hypoxia (8, 10, 42–44). The FN are highly responsive to blood 
CO2 changes, and to a lesser degree, O2 changes, and modulate 
respiration during challenging conditions, but not during normal, 
rhythmic breathing. Cell body lesions of this structure attenuated 
responses to increased levels of environmental CO2, but had no 
effect on breathing patterns in room air conditions (10, 14, 23). 
Structurally, following the loss of 100% of cerebellar Purkinje 
cells, Lc/+ mice exhibit a nearly 60% reduction in FN size, making 
it reasonable to conclude that this loss of volume could reduce 
FN-mediated chemosensitivity (45, 46). Such an inability to 
appropriately detect and respond to increasing CO2 levels could 
increase the risk of a fatal outcome in chemosensitive-related 
extreme challenges, such as those expected in conditions such as 
SIDS or postictal periods in epilepsy patients.
Deficits in serotonergic neural systems may also play a role in 
the current findings. Cerebral serotonin [5-hydroxytryptamine 
(5-HT)] has been repeatedly implicated as integral in respiratory 
modulation, and pathophysiological changes in the number or 
distribution of central 5-HT-containing neurons may play a role in 
disordered breathing associated with sudden unexplained death 
(28, 47, 48). Lc/+ mice, in comparison to controls, show cerebellar 
patterns of disordered 5-HT that include a redistribution of 5-HT 
levels, resulting in increased levels in the deep cerebellar nuclei, 
including the FN, as well as increased serotonin binding in these 
nuclei (49, 50). In normal mice, an extensive 5-HT projection to 
Purkinje cells, originating from medullary and pontine respira-
tory areas exists (51, 52). As Lc/+ mutants lack Purkinje cells, the 
increased 5-HT projection to the deep cerebellar nuclei possibly 
represents a reprograming of this serotonergic projection from 
the Purkinje cells to the deep cerebellar nuclei. This speculative 
reprograming, in turn, may provide an additional contribution 
to the loss of sensitivity to low levels of CO2. Thus, the differences 
FigUre 3 | all data including breaths during 10-s intervals from the middle point of each recovery period (at room air) following exposure to 
successive cO2 challenges (2, 4, 6, and 8%) in an Lc/+ mouse (a–D), and a WT control (e–h). Data are centered on a zero line on the y-axis with inhalations 
falling below the zero line, and exhalations rising above the zero line. The patterns depicted with the above pair were consistent across all Lc/+ mice and wildtype 
controls.
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observed in recovery patterns between Lc/+ and WT mice could 
result from neurochemical events that unfold relative to the 
developmental Purkinje cell loss in Lc/+ mice and further suggest 
an integral role of the cerebellum in respiratory modulation.
Other disorders also exude the characteristic traits of cerebel-
lar neuropathology, including Purkinje cell loss, shrinkage of 
deep cerebellar nuclei, serotonergic disruptions, and disordered 
breathing patterns accompanying unexpected fatalities. Such 
signs are frequently found in epilepsy. People with epilepsy are 
roughly 24 times more likely to die unexpectedly than people 
without epilepsy (53), and ventilatory failure is a major suspect 
in the fatal event. As in SIDS, SUDEP is an exclusionary diagno-
sis, and SUDEP victims are typically found in the prone position 
in bed, which supports the possibility that death has occurred 
during sleep (54, 55). Postmortem examination of the brains of 
patients with chronic epilepsy and SUDEP victims consistently 
reveals cerebellar neuropathology, including cerebellar atrophy 
and Purkinje cell loss (56–58). Examination of the cerebellum 
of SUDEP victims revealed significantly higher amounts of 
Bergmann’s gliosis and folial atrophy compared to age- and 
sex-matched controls (57). Additionally, decreased cerebellar 
Purkinje cell densities in either the anterior or posterior lobe 
appear in SUDEP victims relative to controls (56). Antiepileptic 
drugs (AEDs), specifically phenytoin (Dilantin), exacerbate 
cerebellar atrophy and Purkinje cell loss found in patients 
with epilepsy, and cause cerebellar neuronal damage in both 
humans and animal models (56, 59–63). Additionally, AEDs, 
including phenytoin and benzodiazepines, such as clonazepam 
are  associated with an increased incidence of sleep-disordered 
breathing (64).
Sleep-disordered breathing frequently presents comorbidly 
with epilepsy (64, 65) and even without treatment with AEDs; 
patients report excessive daytime sleepiness, which can be an 
indicator of undiagnosed sleep apnea (66–72). The relevance 
of these findings for the current study is that sleep-disordered 
breathing, even without evidence of epilepsy or AEDs, induces 
significant cerebellar injury (73), and such injury can further 
intensify disturbed respiratory patterning.
Sudden unexplained death in childhood (SUDC), another 
exclusionary fatal event, occurs in children >1 year of age (74). 
It has been speculated that the mechanisms underlying sudden 
death in SIDS, SUDEP, and SUDC may be closely related (75). 
Evidence for such a link includes the finding that SUDC victims 
were significantly more likely to die unexpectedly when one or 
more febrile seizures were experienced (76). Additionally, an 
inverse relationship between SIDS and SUDC cases has recently 
been reported, suggesting that children who die of SUDC may 
have escaped the window of SIDS only to fail to respond appro-
priately to a subsequent exogenous stressor (77). As cerebellar 
neuropathology is often reported in sudden death syndromes, 
such as SIDS and SUDEP (18, 19, 56–58), and because the cerebel-
lum, especially the Purkinje cells, are particularly vulnerable to 
hypoxic insult (78), this raises the suspicion that such pathology 
may be present in the brains of SUDC victims. This possibility, 
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however, has yet to be investigated as research on SUDC is still 
rudimentary.
Human clinical studies have yielded inconsistent support for 
the notion that cerebellar neuropathology is involved in sudden 
death events. For example, in 19 SIDS cases and 12 age-related 
controls, immunohistochemical staining of the cerebellar vermis 
revealed evidence of delayed maturation of the cerebellar cortex 
(18). Further, histological examination at autopsy for 35 cases 
of unexplained death and 20 controls revealed cerebellar cortex 
alterations including delayed maturation and apoptosis of the 
cerebellar Purkinje cells in the sudden unexplained death victims 
but not the controls (19). Conversely, two separate examinations 
of the left and right hemispheres of 12 SIDS victims and age- and 
sex-matched controls revealed no difference between the groups 
in cerebellar Purkinje cell density (79), Purkinje cell layer volume, 
or Purkinje cell number (80). However, as cerebellar Purkinje cells 
are especially vulnerable to even short periods of intermittent 
hypoxia (78), in the aforementioned studies, the use of controls 
who had died from conditions involving hypoxia (e.g., suffoca-
tion, carbon monoxide intoxication, and heart defect) leaves open 
the possibility that differences in Purkinje cell number between 
the two groups were mitigated by circumstances surrounding 
death. Further, these two studies did not examine the cerebellar 
vermis – the area of the cerebellum where the Purkinje cells that 
predominately innervate the FN arise from (81). As the FN is 
one area responsible for modulating chemosensitive responsiv-
ity in  situations such as hypoxia (which are believed to occur 
just prior to unexpected death), it would be of value to include 
examination of the cerebellar vermis in future studies of sudden 
unexpected death victims including SIDS.
Collectively, it appears that developmental damage to the 
cerebellum may play an important role in the development of, or 
vulnerability to serious, and perhaps life-threatening breathing 
patterns in several patient populations. Multiple mechanisms 
may underlie cerebellar Purkinje cell loss, including genetic 
endowment, excitotoxic injury due to excessive neural activation 
in epilepsy, treatment with AEDs, hypoxic injury, and surgical 
insult. Despite various sources of damage to Purkinje cells, the 
present findings suggest that a potential for impaired breathing 
patterns exists, including a reduced ability to recover from mild 
hypercapnia, as demonstrated by a heightened incidence of apneic 
episodes (i.e., increased EEPs). Several patient populations at risk 
for sudden death exhibit a combination of cerebellar neuropathol-
ogy and sleep-disordered breathing, a relationship that suggests 
that cerebellar injury may contribute to inappropriate responses 
following hypercapnic exposure that may lead to seriously com-
promised breathing. The interactions among cerebellar Purkinje 
cells, their output to autonomic- and respiratory-mediating 
FN, and integration with other neurotransmitter systems, such 
as serotonin, that regulate breathing patterns merits continued 
investigation along with the possibility of sex differences similar 
to those reported in the human population in sudden death 
events.
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